Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-22T18:18:18.888Z Has data issue: false hasContentIssue false
  • English
  • Français

Psychotropic drug use in relation to mental disorders and institutionalization among 95-year-olds: a population-based study

Published online by Cambridge University Press:  28 March 2011

Eva Lesén ,
Anders Carlsten ,
Ingmar Skoog ,
Margda Waern ,
Max Petzold  and
Anne Börjesson-Hanson
Eva Lesén*
Affiliation:
Nordic School of Public Health, Gothenburg, Sweden
Anders Carlsten
Affiliation:
Medical Products Agency, Uppsala, Sweden
Ingmar Skoog
Affiliation:
Neuropsychiatric Epidemiology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden
Margda Waern
Affiliation:
Neuropsychiatric Epidemiology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden
Max Petzold
Affiliation:
Nordic School of Public Health, Gothenburg, Sweden
Anne Börjesson-Hanson
Affiliation:
Neuropsychiatric Epidemiology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden
*
Correspondence should be addressed to: Eva Lesén, Nordic School of Public Health, Box 12133, SE-402 42 Gothenburg, Sweden. Phone: +46 31 693 944; Fax: +46 31 691 777. Email: [email protected].
Get access

Abstract

Background: The prevalence of psychotropic drug use is high among the elderly, but research on how psychotropic drugs are used among individuals aged 90 years and older is limited. An increased knowledge on this topic may contribute to improved prescribing patterns in this vulnerable population. The aim of this study was to assess the use of psychotropic drugs in relation to mental disorders and institutionalization among 95-year-olds and to identify use of potentially inappropriate psychotropic drugs.

Methods: All 95-year-olds born in 1901–1903 living in nursing homes or community settings in Gothenburg, Sweden were invited to participate. The response rate was 65% and 338 95-year-olds were examined (263 women, 75 men). Psychotropic drug use in relation to mental disorders and institutionalization was assessed. Information on drug use was collected primarily from multi-dose drug dispensing lists. Participants were examined by trained psychiatrists using the Comprehensive Psychopathological Rating Scale and a battery of cognitive tests. Dementia, depression, anxiety and psychotic disorders were diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, third edition, revised (DSM-III-R).

Results: Sixty percent of the 95-year-old participants used psychotropic drugs; hypnotics were most common (44%). Potentially inappropriate psychotropics were observed in one third (33%). Antidepressants were used by 7% of the participants without dementia who fulfilled criteria for a depressive disorder, while 56% used hypnotics and 30% used anxiolytics.

Conclusions: The high prevalence of psychotropic drug use and the nonspecific nature of these treatments among 95-year-olds indicate a need for improvement in prescribing patterns.

Keywords

psychotropic drugsdrug utilizationmental disordersdementiadepressionnonagenarians
Type
Research Article
Information
International Psychogeriatrics , Volume 23 , Issue 8 , October 2011 , pp. 1270 - 1277
Copyright
Copyright © International Psychogeriatric Association 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised (DSM-III-R). Washington, DC: American Psychiatric Association.Google Scholar
Asberg, M., Montgomery, S. A., Perris, C. and Sedvall, G. (1978). A comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavia, Supplementum, 5–27.CrossRefGoogle Scholar
Bergdahl, E. et al. (2005). Depression among the oldest old: the Umea 85+ study. International Psychogeriatrics, 17, 557–575.CrossRefGoogle ScholarPubMed
Börjesson-Hanson, A., Edin, E., Gislason, T. and Skoog, I. (2004). The prevalence of dementia in 95 year olds. Neurology, 63, 2436–2438.CrossRefGoogle Scholar
Börjesson-Hanson, A., Waern, M., Östling, S., Gustafson, D. and Skoog, I. (2011). One-month prevalence of mental disorders in a population sample of 95-year olds. American Journal of Geriatric Psychiatry, 19, 284–291.CrossRefGoogle Scholar
Briesacher, B. A. et al. (2005). The quality of antipsychotic drug prescribing in nursing homes. Archives of Internal Medicine, 165, 1280–1285.CrossRefGoogle ScholarPubMed
Bryant, C., Jackson, H. and Ames, D. (2008). The prevalence of anxiety in older adults: methodological issues and a review of the literature. Journal of Affective Disorders, 109, 233–250.CrossRefGoogle Scholar
Carlsten, A., Waern, M., Ekedahl, A. and Ranstam, J. (2001). Antidepressant medication and suicide in Sweden. Pharmacoepidemiology and Drug Safety, 10, 525–530.CrossRefGoogle ScholarPubMed
Engberg, H., Oksuzyan, A., Jeune, B., Vaupel, J. W. and Christensen, K. (2009). Centenarians – a useful model for healthy aging? A 29-year follow-up of hospitalizations among 40,000 Danes born in 1905. Aging Cell, 8, 270–276.CrossRefGoogle Scholar
Fialova, D. et al. (2005). Potentially inappropriate medication use among elderly home care patients in Europe. JAMA, 293, 1348–1358.CrossRefGoogle ScholarPubMed
Forsell, Y. and Winblad, B. (1997). Psychiatric disturbances and the use of psychotropic drugs in a population of nonagenarians. International Journal of Geriatric Psychiatry, 12, 533–536.3.0.CO;2-X>CrossRefGoogle Scholar
Gill, S. S. et al. (2007). Antipsychotic drug use and mortality in older adults with dementia. Annals of Internal Medicine, 146, 775–786.CrossRefGoogle ScholarPubMed
Giron, M. S., Forsell, Y., Bernsten, C., Thorslund, M., Winblad, B. and Fastbom, J. (2001a). Psychotropic drug use in elderly people with and without dementia. International Journal of Geriatric Psychiatry, 16, 900–906.CrossRefGoogle ScholarPubMed
Giron, M. S., Wang, H. X., Bernsten, C., Thorslund, M., Winblad, B. and Fastbom, J. (2001b). The appropriateness of drug use in an older nondemented and demented population. Journal of the American Geriatrics Society, 49, 277–283.CrossRefGoogle Scholar
Linden, M., Bar, T. and Helmchen, H. (2004). Prevalence and appropriateness of psychotropic drug use in old age: results from the Berlin Aging Study (BASE). International Psychogeriatrics, 16, 461–480.CrossRefGoogle ScholarPubMed
Mangoni, A. A. and Jackson, S. H. (2004). Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. British Journal of Clinical Pharmacology, 57, 6–14.CrossRefGoogle ScholarPubMed
National Board of Health and Welfare (2004). Indicators for Evaluation of the Quality in Drug Use among the Elderly: Proposal from the National Board of Health and Welfare. Report number 2003-110-20. Stockholm: National Board of Health and Welfare.Google Scholar
Nelson, E. A. and Dannefer, D. (1992). Aged heterogeneity: fact or fiction? The fate of diversity in gerontological research. Gerontologist, 32, 17–23.CrossRefGoogle ScholarPubMed
Ostling, S., Borjesson-Hanson, A. and Skoog, I. (2007). Psychotic symptoms and paranoid ideation in a population-based sample of 95-year-olds. American Journal of Geriatric Psychiatry, 15, 999–1004.CrossRefGoogle Scholar
Rapoport, M., Mamdani, M., Shulman, K. I., Herrmann, N. and Rochon, P. A. (2005). Antipsychotic use in the elderly: shifting trends and increasing costs. International Journal of Geriatric Psychiatry, 20, 749–753.CrossRefGoogle ScholarPubMed
Rudolph, J. L., Salow, M. J., Angelini, M. C. and McGlinchey, R. E. (2008). The anticholinergic risk scale and anticholinergic adverse effects in older persons. Archives of Internal Medicine, 168, 508–513.CrossRefGoogle ScholarPubMed
Sacchetti, E., Turrina, C. and Valsecchi, P. (2010). Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review. Drug Safety, 33, 273–288.CrossRefGoogle ScholarPubMed
Sambamoorthi, U., Olfson, M., Walkup, J. T. and Crystal, S. (2003). Diffusion of new generation antidepressant treatment among elderly diagnosed with depression. Medical Care, 41, 180–194.CrossRefGoogle ScholarPubMed
Schmidt, I., Claesson, C. B., Westerholm, B. and Svarstad, B. L. (1998). Resident characteristics and organizational factors influencing the quality of drug use in Swedish nursing homes. Social Science and Medicine, 47, 961–971.CrossRefGoogle ScholarPubMed
Skoog, I., Nilsson, L., Landahl, S. and Steen, B. (1993). Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. International Psychogeriatrics, 5, 33–48.CrossRefGoogle Scholar
Statistics Sweden (2010). The Statistical Database: Population Statistics, Population by Age and Sex, 2010–2110. Available at: www.ssd.scb.se; last accessed 16 December 2010.Google Scholar
Strothers, H. S. 3rd, Rust, G., Minor, P., Fresh, E., Druss, B. and Satcher, D. (2005). Disparities in antidepressant treatment in Medicaid elderly diagnosed with depression. Journal of the American Geriatrics Society, 53, 456–461.CrossRefGoogle ScholarPubMed
Trifiro, G., Spina, E. and Gambassi, G. (2009). Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile? Pharmacological Research, 59, 1–12.CrossRefGoogle ScholarPubMed
Tu, K., Mamdani, M. M., Hux, J. E. and Tu, J. B. (2001). Progressive trends in the prevalence of benzodiazepine prescribing in older people in Ontario, Canada. Journal of the American Geriatrics Society, 49, 1341–1345.CrossRefGoogle ScholarPubMed
WHO Collaborating Centre for Drug Statistics Methodology (2009). ATC Index with DDDs. Available at: www.whocc.no. Last accessed 11 May 2009.Google Scholar
Wilson, K. and Mottram, P. (2004). A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis. International Journal of Geriatric Psychiatry, 19, 754–762.CrossRefGoogle ScholarPubMed